147 related articles for article (PubMed ID: 1854833)
21. Oncogenes and metastatic progression.
Greenberg AH; Egan SE; Wright JA
Invasion Metastasis; 1989; 9(6):360-78. PubMed ID: 2689384
[TBL] [Abstract][Full Text] [Related]
22. v-myc and v-raf act synergistically to induce B-cell tumors in pristane-primed adult BALBC mice.
Kurie JM; Morse HC; Principato MA; Wax JS; Troppmair J; Rapp UR; Potter M; Mushinski JF
Oncogene; 1990 Apr; 5(4):577-82. PubMed ID: 2183159
[TBL] [Abstract][Full Text] [Related]
23. Phenotypic changes induced by wild type and variant c-src genes carrying C-terminal sequence alterations.
Yatsula BA; Plachy J; Mikhailik A; David-Pfeuty T; Lecoq O; Yatsula V; Geryk J; Svoboda J; Calothy G; Dezélée P
Oncogene; 1996 Dec; 13(12):2717-25. PubMed ID: 9000146
[TBL] [Abstract][Full Text] [Related]
24. Synergism between pairs of immortalizing genes in transformation assays of rat embryo fibroblasts.
Peacock JW; Matlashewski GJ; Benchimol S
Oncogene; 1990 Dec; 5(12):1769-74. PubMed ID: 2178238
[TBL] [Abstract][Full Text] [Related]
25. v-Ras and v-Raf block differentiation of transformable C3H10T1/2-derived preadipocytes at lower levels than required for neoplastic transformation.
Raptis L; Brownell HL; Lu Y; Preston T; Narsimhan RP; Anderson S; Schaefer E; Haliotis T
Exp Cell Res; 1997 Aug; 235(1):188-97. PubMed ID: 9281368
[TBL] [Abstract][Full Text] [Related]
26. C127 cells resistant to transformation by tyrosine protein kinase oncogenes.
Cuadrado A; Talbot N; Barbacid M
Cell Growth Differ; 1990 Jan; 1(1):9-15. PubMed ID: 2150330
[TBL] [Abstract][Full Text] [Related]
27. Turning on tumors to study cancer progression.
Berns A
Nat Med; 1999 Sep; 5(9):989-90. PubMed ID: 10470069
[No Abstract] [Full Text] [Related]
28. Genetic interaction between Rb and N-ras: differentiation control and metastasis.
Takahashi C; Ewen ME
Cancer Res; 2006 Oct; 66(19):9345-8. PubMed ID: 17018584
[TBL] [Abstract][Full Text] [Related]
29. Oncogenes and epithelial cell transformation.
Reichmann E
Semin Cancer Biol; 1994 Apr; 5(2):157-65. PubMed ID: 8061331
[TBL] [Abstract][Full Text] [Related]
30. The v-myc oncogene.
Lee CM; Reddy EP
Oncogene; 1999 May; 18(19):2997-3003. PubMed ID: 10378695
[TBL] [Abstract][Full Text] [Related]
31. Isolation of murine fetal thymus cell lines after infection with recombinant retroviruses containing the v-myc and v-Ha-ras oncogenes.
Cattermole JA; Crosier PS; Leung E; Overell RW; Gillis S; Watson JD
J Immunol; 1989 Jun; 142(11):3746-53. PubMed ID: 2523933
[TBL] [Abstract][Full Text] [Related]
32. Critical role of Rho in cell transformation by oncogenic Ras.
Prendergast GC; Khosravi-Far R; Solski PA; Kurzawa H; Lebowitz PF; Der CJ
Oncogene; 1995 Jun; 10(12):2289-96. PubMed ID: 7784077
[TBL] [Abstract][Full Text] [Related]
33. Morphological alteration of X-ray induced partially transformed human cells by transfection with a small c-myc DNA sequence.
Kano Y; Nohno T; Takahashi R; Hiragami F; Kawamura K; Strebhardt K; Namba M; Sugiyama T; Little JB
Biochem Biophys Res Commun; 2000 Jun; 272(3):887-94. PubMed ID: 10860847
[TBL] [Abstract][Full Text] [Related]
34. Stage-specific transformation of murine B lineage cells by ras and myc.
Overell RW; Weisser KE; Hess B; Namen AE; Grabstein KH
Oncogene; 1989 Dec; 4(12):1425-32. PubMed ID: 2687765
[TBL] [Abstract][Full Text] [Related]
35. Neoplastic transformation dose response of oncogene-transfected rat embryo cells by gamma rays or 6 MeV alpha particles.
Ling CC; Weiss H; Strauss A; Endlich B; Sheh Y; Wei JX; Orazem J
Radiat Res; 1994 Apr; 138(1):79-85. PubMed ID: 8146303
[TBL] [Abstract][Full Text] [Related]
36. Smad7 but not Smad6 cooperates with oncogenic ras to cause malignant conversion in a mouse model for squamous cell carcinoma.
Liu X; Lee J; Cooley M; Bhogte E; Hartley S; Glick A
Cancer Res; 2003 Nov; 63(22):7760-8. PubMed ID: 14633701
[TBL] [Abstract][Full Text] [Related]
37. [Oncogene cooperation in cellular transformation].
Samarut J
Reprod Nutr Dev; 1990; 30(3):361-78. PubMed ID: 2204350
[TBL] [Abstract][Full Text] [Related]
38. Oncogenic pathways impinging on the G2-restriction point.
Foijer F; Simonis M; van Vliet M; Wessels L; Kerkhoven R; Sorger PK; Te Riele H
Oncogene; 2008 Feb; 27(8):1142-54. PubMed ID: 17700522
[TBL] [Abstract][Full Text] [Related]
39. [Development of oncogene study].
Toyoshima K
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):497-503. PubMed ID: 6309088
[TBL] [Abstract][Full Text] [Related]
40. [Retrovirus, oncogenes and malignant transformation].
Fernández-Cruz E
Rev Clin Esp; 1986 Nov; 179(8):389-91. PubMed ID: 3031749
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
